Developing Sexual and Reproductive Health Educational Resources for Young Women with Cystic Fibrosis: A Structured Approach to Stakeholder Engagement.


Journal

The patient
ISSN: 1178-1661
Titre abrégé: Patient
Pays: New Zealand
ID NLM: 101309314

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 27 10 2018
medline: 13 7 2019
entrez: 27 10 2018
Statut: ppublish

Résumé

Stakeholder engagement, specifically integration of patient and family perspectives about what matters, is increasingly recognized as a critical component of patient-centered healthcare delivery. This study describes a structured approach to and evaluation of stakeholder engagement in the development of novel sexual and reproductive health (SRH) educational resources for adolescent and young adult (AYA) women with cystic fibrosis (CF). Key stakeholders participated in a systematic series of steps to iteratively develop and adapt patient educational resources. Process measures (stakeholder recruitment, composition, co-learning, and transparency) and proximal outcomes of stakeholder involvement (impact on the development process and satisfaction) were measured via recorded stakeholder recommendations and a stakeholder survey. Seventeen stakeholders participated in seven group and two patient-only conference calls. The majority of stakeholders understood their roles, had their expectations met or exceeded, and were satisfied with the frequency and quality of engagement in the project. All stakeholders in attendance provided multiple concrete recommen-dations during the development process. Stakeholders explored the motivations of AYA women with CF related to SRH and agreed that the ideal resource should be online. After reviewing the design of existing resources, stakeholders decided by consensus to partner with a pre-existing young women's health website and created 11 CF-specific SRH guides. This study illuminates a path for a formal process of stakeholder engagement and evaluation in educational resource development centered on the SRH care needs of AYA women with CF. Similar systematic, planned processes could be extended to other populations and aspects of healthcare.

Identifiants

pubmed: 30361885
doi: 10.1007/s40271-018-0342-4
pii: 10.1007/s40271-018-0342-4
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-276

Subventions

Organisme : Cystic Fibrosis Foundation
ID : KAZMER16A0
Pays : International

Références

Clin Rev Allergy Immunol. 2010 Apr;38(2-3):302-6
pubmed: 19603147
J Technol Hum Serv. 2018;35(3):169-182
pubmed: 29743822
Eur Respir J. 2012 Oct;40(4):881-5
pubmed: 22282544
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D117-26
pubmed: 24355636
J Cyst Fibros. 2018 Jan;17(1):64-70
pubmed: 28866451
Disabil Health J. 2017 Jul;10(3):413-418
pubmed: 28428111
Pediatrics. 2014 Jun;133(6):e1639-46
pubmed: 24843066
Am J Prev Med. 2009 Feb;36(2):165-73
pubmed: 19135907
Arch Pediatr Adolesc Med. 1999 Jan;153(1):27-32
pubmed: 9894996
J Sex Med. 2015 Dec;12(12):2350-63
pubmed: 26633081
J Cyst Fibros. 2018 Jan;17(1):57-63
pubmed: 28774749
Health Aff (Millwood). 2009 Mar-Apr;28(2):361-8
pubmed: 19275991
J Pediatr Oncol Nurs. 2007 Sep-Oct;24(5):255-63
pubmed: 17827491
Blood. 2010 Apr 29;115(17):3447-52
pubmed: 20194891
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):418-24
pubmed: 25696888
Health Aff (Millwood). 2010 Oct;29(10):1834-41
pubmed: 20921483
BMJ Qual Saf. 2016 Jul;25(7):509-17
pubmed: 26376674
Lancet. 2007 Apr 28;369(9571):1481-1489
pubmed: 17467519
N Engl J Med. 2004 Jun 24;350(26):2654-62
pubmed: 15215481
J Comp Eff Res. 2017 Jun;6(4):375-389
pubmed: 28621551
Fam Pract. 2013 Feb;30(1):64-8
pubmed: 22843639
Dev Med Child Neurol. 2007 Feb;49(2):86-92
pubmed: 17253993
J Gen Intern Med. 2014 Dec;29(12):1692-701
pubmed: 24893581
J Pediatr Adolesc Gynecol. 2017 Oct;30(5):546-552
pubmed: 28163120
Pediatr Transplant. 2015 Nov;19(7):704-8
pubmed: 26260626
Lancet Respir Med. 2015 Jan;3(1):70-86
pubmed: 25529340
BMJ Open. 2014 Feb 05;4(2):e004081
pubmed: 24500612
Pediatrics. 2016 Jun;137(6):
pubmed: 27244858
Eval Health Prof. 2013 Mar;36(1):73-92
pubmed: 22523308

Auteurs

Traci M Kazmerski (TM)

Division of Adolescent and Young Adult Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University Center, 120 Lytton Ave, Mezzanine Floor Suite M060, Pittsburgh, PA, 15213, USA. traci.kazmerski@chp.edu.
Center for Women's Health Research and Innovation (CWHRI), University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. traci.kazmerski@chp.edu.

Elizabeth Miller (E)

Division of Adolescent and Young Adult Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University Center, 120 Lytton Ave, Mezzanine Floor Suite M060, Pittsburgh, PA, 15213, USA.
Center for Women's Health Research and Innovation (CWHRI), University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Gregory S Sawicki (GS)

Division of Respiratory Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Phaedra Thomas (P)

Division of Adolescent/Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Olga Prushinskaya (O)

Division of Respiratory Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Eliza Nelson (E)

Division of Respiratory Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Kelsey Hill (K)

Division of Respiratory Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Anna Miller (A)

Division of Adolescent/Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

S Jean Emans (S)

Division of Adolescent/Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH